TD-9855 Mass Balance Study
NCT01924143
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
6
Enrollment
INDUSTRY
Sponsor class
Conditions
ADHD
Fibromyalgia
Interventions
DRUG:
TD-9855
Sponsor
Theravance Biopharma